Your browser doesn't support javascript.
loading
Early-onset leukoencephalopathy due to a homozygous missense mutation in the DARS2 gene.
Köhler, Cornelia; Heyer, Christoph; Hoffjan, Sabine; Stemmler, Susanne; Lücke, Thomas; Thiels, Charlotte; Kohlschütter, Alfried; Löbel, Ulrike; Horvath, Rita; Kleinle, Stephanie; Benet-Pages, Anna; Abicht, Angela.
Affiliation
  • Köhler C; Department of Neuropediatrics, University Children's Hospital, Ruhr-University Bochum, Germany. Electronic address: c.koehler@klinikum-bochum.de.
  • Heyer C; Institute of Pediatric Radiology, University Children's Hospital, Ruhr-University Bochum, Germany.
  • Hoffjan S; Department of Human Genetics, Ruhr-University Bochum, Germany.
  • Stemmler S; Department of Human Genetics, Ruhr-University Bochum, Germany.
  • Lücke T; Department of Neuropediatrics, University Children's Hospital, Ruhr-University Bochum, Germany.
  • Thiels C; Department of Neuropediatrics, University Children's Hospital, Ruhr-University Bochum, Germany.
  • Kohlschütter A; University Medical Center Hamburg, Germany.
  • Löbel U; Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Horvath R; Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, Great Britain, UK.
  • Kleinle S; Medical Genetics Centre, Munich, Germany.
  • Benet-Pages A; Medical Genetics Centre, Munich, Germany.
  • Abicht A; Medical Genetics Centre, Munich, Germany.
Mol Cell Probes ; 29(5): 319-22, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26327357
ABSTRACT
Mutations in the DARS2 gene are known to cause leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL), a rare autosomal recessive neurological disorder. It was originally described as juvenile-onset slowly progressive ataxia and spasticity, but recent reports suggest a broader clinical spectrum. Most patients were found to carry compound heterozygous DARS2 mutations, and only very few patients with homozygous mutations have been described so far. We present here an 8-month-old boy carrying a homozygous missense mutation in DARS2 who clinically showed severe neurological deterioration after a respiratory tract infection, followed by an almost complete remission of symptoms. This report further extends the knowledge about the clinical and molecular genetic spectrum of LBSL.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspartate-tRNA Ligase / Mutation, Missense / Leukoencephalopathies Type of study: Diagnostic_studies Limits: Humans / Infant / Male Language: En Journal: Mol Cell Probes Journal subject: BIOLOGIA MOLECULAR / BIOTECNOLOGIA Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspartate-tRNA Ligase / Mutation, Missense / Leukoencephalopathies Type of study: Diagnostic_studies Limits: Humans / Infant / Male Language: En Journal: Mol Cell Probes Journal subject: BIOLOGIA MOLECULAR / BIOTECNOLOGIA Year: 2015 Type: Article